Anthera Pharmaceuticals Inc
OTC:ANTH

Watchlist Manager
Anthera Pharmaceuticals Inc Logo
Anthera Pharmaceuticals Inc
OTC:ANTH
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 2.6k USD

Operating Margin
Anthera Pharmaceuticals Inc

0%
Current
-5 050%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-36.8m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Anthera Pharmaceuticals Inc
Glance View

Market Cap
2.6k USD
Industry
Biotechnology

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. The company is headquartered in Hayward, California and currently employs 21 full-time employees. The company went IPO on 2010-03-02. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.

ANTH Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-36.8m
/
Revenue
0
What is the Operating Margin of Anthera Pharmaceuticals Inc?

Based on Anthera Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top